PMID: 3135010Jun 4, 1988Paper

Stroke and coronary heart disease in mild hypertension: risk factors and the value of treatment. Medical Research Council Working Party

British Medical Journal


Further analyses of the Medical Research Council's trial of drug treatment of mild hypertension were carried out to provide more detailed information on the benefits associated with treatment in various subgroups. The four main considerations in establishing a rational treatment policy were, firstly, the significant reduction in the stroke rate with active treatment; secondly, the absence of a significant overall treatment effect on myocardial infarction; thirdly, the knowledge that of 100 untreated men in the highest risk group (those aged 55-64 with high systolic pressure at entry who smoked), five would be expected to suffer a stroke and 10 a coronary event within five years; and, fourthly, the cost, in clinical and financial terms, of prolonged treatment. In the high risk group of 100 men treatment with bendrofluazide would result in the prevention of three or four of the five strokes but would have little effect on the expected numbers of myocardial infarctions. Treatment with propranolol in non-smoking men in the highest age and blood pressure categories would lead to a reduction in the number having strokes from three to one or two and might possibly reduce the number experiencing myocardial infarction from seven to four...Continue Reading


Jun 1, 1995·Clinical Cardiology·C J Kaupke
Dec 1, 1992·Cardiovascular Drugs and Therapy·L H Opie
Jan 23, 1992·The New England Journal of Medicine·A E Fletcher, C J Bulpitt
Apr 1, 1990·British Journal of Clinical Pharmacology·D MacleanD G McDevitt
Aug 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·R J Jarrett, A P Fitzgerald
Jul 29, 2006·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Serena Tonstad, J Andrew Johnston
Apr 10, 2010·Journal of Women's Health·Charlotta LjungmanKarin Manhem
Oct 9, 1998·BMJ : British Medical Journal·M I Aldoori, S H Rahman
Apr 1, 1990·International Disability Studies·R EldarL Epstein
Nov 21, 2008·Clinical and Experimental Hypertension : CHE·Francesco AmentaFranco Veglio
Jan 1, 1992·Clinical and Experimental Hypertension. Part A, Theory and Practice·C G Isles, D J Hole
Jan 1, 1989·Clinical and Experimental Hypertension. Part A, Theory and Practice·J J McNeil
Jul 1, 1995·Clinical and Experimental Hypertension : CHE·M SabbatiniF Amenta
Mar 24, 2009·Journal of the Neurological Sciences·Francesco AmentaDaniele Tomassoni
Jan 1, 1990·Journal of Clinical Epidemiology·S G Thompson, S J Pocock
Apr 19, 2018·The Cochrane Database of Systematic Reviews·James M WrightRupam Gill
Aug 17, 2017·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Jul 10, 2009·The Cochrane Database of Systematic Reviews·James M Wright, Vijaya M Musini
Mar 1, 1992·Stroke; a Journal of Cerebral Circulation·S KeliD Kromhout
Jun 5, 2003·Hypertension·Andrew D BlannGregory Y H Lip
Oct 13, 2018·British Journal of Clinical Pharmacology·Tatiana V MacfarlaneThomas M MacDonald
May 11, 1991·BMJ : British Medical Journal·A G ShaperP W Macfarlane
Feb 10, 1990·BMJ : British Medical Journal
Jun 1, 1991·Journal of Epidemiology and Community Health·R ShintonG Rose
Jun 6, 2019·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
May 20, 1998·British Journal of Urology·A J Man In't VeldK van Loon
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Diana DiaoFrancois Gueyffier

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.